Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Advanced Materials Regulatory News (MGAM)

Share Price Information for Morgan Advanced Materials (MGAM)

Share Price is delayed by 15 minutes
Get Live Data
228.00    -1.50 (-0.65%)
Bid:
227.00
Ask:
227.50
Spread: 0.50 (0.22%)
Market Cap: £630.23m
MGAM Live PriceLast checked at - London Stock Exchange

Intraday Morgan Advanced Materials Share Chart

Trading Update

12 Nov 2015 07:00

RNS Number : 4277F
Morgan Advanced Materials PLC
12 November 2015
 



 

Press Release

Trading Update

Morgan Advanced Materials plc

12th November 2015

 

 

Morgan Advanced Materials plc, the advanced materials company, is today issuing the following trading update covering the period from 1st July 2015 to 11th November 2015.

 

Trading conditions in the period since the half year have weakened across the Group with North America and China particularly affected by deteriorating demand. Overall our order book has mirrored this weakness, but with a mixed profile across the geographies, businesses and end markets in which we operate.

 

At the end of October the YTD book to bill ratio was 1.00 (June 2015 -1.03). The outstanding order book at the end of October was 5.3% below last year (June 2015 - 5.7% higher than the June 2014). Given this order profile, the Group expects that reported revenue in the second half of the year will be c7% below the first half of 2015 and that EBITA before restructuring and one-offs will be around the lower end of the range of analyst expectations.

 

The North American region has been the most affected by economic slowdown. General industrial demand weakness has been seen across our business over the last four months particularly oil and gas, transportation and mining markets.

 

In Europe the Thermal Ceramics business has continued to trade well, offset by weak demand in Technical Ceramics, Seals and Bearings and Composites and Defence Systems.

 

Asia/ROW has continued to see very weak demand in China, which has impacted both the products manufactured in-region for industrial markets and also those sold in to China from Morgan businesses in North America and Europe. The rest of Asia has shown some weakness in parts of its demand environment, but overall has been fairly resilient. Weak economic conditions in South America, particularly in Brazil and Argentina, are impacting the performance of our mainly industrial business in the region.

 

The Group is cautious about the trading and macro-economic environment for the rest of this year, and into 2016, and the Group has undertaken a range of cost reduction measures in line with this weakening economic environment and will continue to take further action as necessary. The cash cost for these restructuring and one-off items is estimated to be low, in the region of £3 million. Against this challenging market, the Group continues to invest in R&D and profitable growth opportunities which are critical for the future. Such investment is underpinned by solid cash flow and a strong balance sheet, with low net debt estimated to be c1.5 times EBITDA at the end of 2015.

 

Morgan's preliminary results for the year ended 31st December 2015 will be announced on 23rd February 2016.

 

(Note:

Current market expectations compiled from analyst notes for EBITA before restructuring and one-off items range from £110.0 million to £121.5 million).

 

 

 

 

 

 

For further enquiries:

 

Pete Raby/Kevin Dangerfield

Morgan Advanced Materials plc

01753 837000

Mike Smith/Nina Coad

Brunswick

0207 404 5959

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTPKDDDFBDDODD
Date   Source Headline
26th Sep 202312:24 pmRNSDirector/PDMR Shareholding
16th Aug 202311:27 amRNSDirector/PDMR Shareholding
7th Aug 20235:24 pmRNSDirector/PDMR Shareholding
4th Aug 20237:00 amRNSHalf-Year Results for Period Ended 30 June 2023
13th Jul 20234:49 pmRNSDirector/PDMR Shareholding
5th Jul 20234:51 pmRNSDirector/PDMR Shareholding
29th Jun 20235:06 pmRNSResult of AGM
29th Jun 20237:00 amRNSH1 Trading Update
22nd Jun 202311:50 amRNSBlock listing Interim Review
31st May 20233:52 pmRNSDirector/PDMR Shareholding
26th May 20233:28 pmRNSNotice of Annual General Meeting 2023
24th May 20233:59 pmRNSDirector/PDMR Shareholding
11th May 202312:06 pmRNSDirector/PDMR Shareholding
11th May 202312:01 pmRNSDirector/PDMR Shareholding
11th May 202311:59 amRNSDirector/PDMR Shareholding
9th May 20235:59 pmRNSDirector/PDMR Shareholding
4th May 20235:28 pmRNSAnnual Report & Accounts 2022
3rd May 20235:38 pmRNSDirector/PDMR Shareholding
3rd May 20235:28 pmRNSDirector/PDMR Shareholding
28th Apr 20235:45 pmRNSInformation required by DTR 4.1
28th Apr 20237:00 amRNSFull-year results for the period ended 31 Dec 2022
13th Apr 20237:00 amRNSNotification of Full-Year Results
7th Feb 20237:00 amRNSUpdate on Trading and Cyber Security Incident
18th Jan 20237:00 amRNSAppointment of Chair Designate
10th Jan 20237:00 amRNSNotice of Cyber Security Incident
22nd Dec 202211:01 amRNSBlock listing Interim Review
16th Dec 20224:44 pmRNSHolding(s) in Company
6th Dec 20227:00 amRNSAccelerated Pension Contribution
6th Dec 20227:00 amRNSCapital Markets Event
23rd Nov 202210:01 amRNSDirector/PDMR Shareholding
15th Nov 20225:06 pmRNSDirector/PDMR Shareholding
10th Nov 20228:03 amRNSDirector Declaration
4th Nov 20227:00 amRNSTrading Update
17th Oct 20222:21 pmRNSDirector/PDMR Shareholding
26th Sep 202212:52 pmRNSDirector/PDMR Shareholding
26th Sep 202212:49 pmRNSDirector/PDMR Shareholding
29th Jul 20227:00 amRNSHalf-year results
15th Jun 20229:30 amRNSBlock listing Interim Review
1st Jun 202210:00 amRNSDirector/PDMR Shareholding
31st May 202210:06 amRNSDirector/PDMR Shareholding
24th May 20222:32 pmRNSDirector/PDMR Shareholding
16th May 20222:52 pmRNSDirector/PDMR Shareholding
5th May 20223:12 pmRNSDirectorate Change
5th May 20222:00 pmRNSResult of AGM
5th May 20227:00 amRNSQ1 trading update
3rd May 20222:45 pmRNSHolding in Company
14th Apr 20222:59 pmRNSHolding(s) in Company
30th Mar 20223:25 pmRNSAnnual Financial Report
28th Mar 202212:00 pmRNSHolding in Company
23rd Mar 202211:02 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.